1 Min Read
Feb 21 (Reuters) - Valeant Pharmaceuticals International is near a deal to buy Salix Pharmaceuticals Ltd for about $10 billion, the Wall Street Journal reported on Saturday. (Reporting by Eric Beech)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.